Search research articles
Contact Us
Filters
Showing results (121-130 of 198) with videos related to
Page
of 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2007
Platelets take up the monoclonal antibody bevacizumab
Henk M W Verheul, Martijn P J Lolkema, David Z Qian, et al.
Urology
|
October 16, 2013
Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer
Shabnam Rehman, Alice Crane, Rakeeba Din, et al.
British Journal of Cancer
|
November 1, 2019
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
Giosue Scognamiglio, Annarosaria De Chiara, Antonina Parafioriti, et al.
Urologic Oncology
|
September 22, 2014
Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)
Andrew J Armstrong, Reza Kaboteh, Michael A Carducci, et al.
Cancer
|
June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study
David J Vaughn, Sandy Srinivas, Walter M Stadler, et al.
Free Radical Biology & Medicine
|
August 6, 2011
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells
Piergiorgio Pettazzoni, Eric Ciamporcero, Claudio Medana, et al.
Clinical Genitourinary Cancer
|
October 29, 2015
Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
Venkata K Pokuri, Johar R Syed, Zhengyu Yang, et al.
Investigational New Drugs
|
May 26, 2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
Michael R Harrison, Noah M Hahn, Roberto Pili, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 7, 2009
Concordance of cancer patients' function, symptoms, and supportive care needs
Claire F Snyder, Elizabeth Garrett-Mayer, Amanda L Blackford, et al.
Clinical Genitourinary Cancer
|
May 27, 2017
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])
Roberto Pili, Opeyemi Jegede, Michael A Carducci, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 198) with videos related to
Sort By:
Page
of 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2007
Platelets take up the monoclonal antibody bevacizumab
Henk M W Verheul, Martijn P J Lolkema, David Z Qian, et al.
Urology
|
October 16, 2013
Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer
Shabnam Rehman, Alice Crane, Rakeeba Din, et al.
British Journal of Cancer
|
November 1, 2019
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
Giosue Scognamiglio, Annarosaria De Chiara, Antonina Parafioriti, et al.
Urologic Oncology
|
September 22, 2014
Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)
Andrew J Armstrong, Reza Kaboteh, Michael A Carducci, et al.
Cancer
|
June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study
David J Vaughn, Sandy Srinivas, Walter M Stadler, et al.
Free Radical Biology & Medicine
|
August 6, 2011
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells
Piergiorgio Pettazzoni, Eric Ciamporcero, Claudio Medana, et al.
Clinical Genitourinary Cancer
|
October 29, 2015
Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
Venkata K Pokuri, Johar R Syed, Zhengyu Yang, et al.
Investigational New Drugs
|
May 26, 2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
Michael R Harrison, Noah M Hahn, Roberto Pili, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 7, 2009
Concordance of cancer patients' function, symptoms, and supportive care needs
Claire F Snyder, Elizabeth Garrett-Mayer, Amanda L Blackford, et al.
Clinical Genitourinary Cancer
|
May 27, 2017
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])
Roberto Pili, Opeyemi Jegede, Michael A Carducci, et al.
Page
of 20